京都大学大学院医学研究科 血液・腫瘍内科学

研究

ホーム ＞ 研究 ＞ 臨床研究グループ

臨床研究グループ

2018年の業績

  • Nishi K, Kanda J, Hishizawa M, Kitano T, Kondo T, Yamashita K, Takaori-kondo A. The impact of the use and type of antibiotics on acute graft-versus-host disease. Biol Blood Marrow Transplant . 24(11): 2178-2183, 2018.
  • Sakaguchi M, Yamaguchi H, Najima Y, Usuki K, Ueki T, Oh I, Mori S, Kawata E, Uoshima N, Kobayashi Y, Kako S, Tajika K, Gomi S, Shono K, Kayamori K, Hagihara M, Kanda J , Uchiyama H, Kuroda J, Uchida N, Kubota Y, Kimura S, Kurosawa S, Nakajima N, Marumo A, Omori I, Fujiwara Y, Yui S, Wakita S, Arai K, Kitano T, Kakihana K, Kanda Y, Ohashi K, Fukuda T, Inokuchi K. Prognostic impact of low allelic ratio FLT3-ITD and NPM1 mutation in acute myeloid leukemia. Blood Adv . 2(20): 2744-2754, 2018.
  • Iemura T, Itoh M, Mano C, Oba A, Kawabata N, Horisawa Y, Matsui M, Miyahara Y, Kanda J. Successful engraftment after cord blood transplantation from an HLA-homozygous donor (homo-to-hetero cord blood transplantation) in a primary myelofibrosis patient with broad HLA antibodies. Transfusion . 58(12): 2773-2776, 2018.
  • Konuma T, Yanada M, Yamasaki S, Kuwatsuka Y, Fukuda T, Kobayashi T, Ozawa Y, Uchida N, Ota S, Hoshino T, Takahashi S, Kanda Y, Ueda Y, Takanashi M, Kanda J, Ichinohe T, Atsuta Y, Yano S. Allogeneic haematopoietic cell transplantation for adult acute myeloid leukaemia in second remission: a retrospective study of the Adult Acute Myeloid Leukaemia Working Group of the Japan Society for Haematopoietic Cell Transplantation (JSHCT). Br J Haematol . 182(2): 245-250, 2018.
  • Konuma T, Mizuno S, Kondo T, Yamaguchi H, Fukuda T, Uchida N, Ohashi K, Kanamori H, Ota S, Nakamae H, Nakamae M, Mizuno I, Sugita J, Onishi Y, Yokota A, Takahashi S, Kanda Y, Ichinohe T, Atsuta Y, and Yano S. Allogeneic hematopoietic cell transplantation in adult acute myeloid leukemia with 11q23 abnormality: a retrospective study of the Adult Acute Myeloid Leukemia Working Group of the Japan Society for Hematopoietic Cell Transplantation (JSHCT). Ann Hematol . 97(11): 2173-2183, 2018.
  • Tomizawa D, Yoshida M, Kondo T, Miyamura T, Taga T, Adachi S, Koh K, Noguchi M, Kakuda H, Watanabe K, Cho Y, Fukuda T, Kato M, Shiba N, Goto H, Okada K, Inoue M, Hashii Y, Atsuta Y, Ishida H. Allogeneic hematopoietic stem cell transplantation for children and adolescents with high-risk cytogenetic AML: Distinctly poor outcomes of FUS-ERG-positive cases. Bone Marrow Transplant . 54(3): 393-401, 2018
  • Ito T, Kondo T, Yamashita K, Takaori-Kondo A. A single-center retrospective analysis of extramedullary relapse after allogeneic stem cell transplantation for myeloid neoplasms. Journal of Hematopoiet . 7(4): 138-144, 2018.
  • Tozatto-Maio K, Giannotti F, Labopin M, Ruggeri A, Volt F, Paviglianiti A, Kenzey C, Hayashi H, Cornelissen J, Michallet M, Karakasis D, Deconinck E, Rohrlich PS, de la Tour RP, Blaise D, Petersen E, D'Aveni M, Sengeloev H, Lamy T, Russell NH, Forcade E, Craddock CF, Nagler A, Gluckman E, Rocha V. Cord Blood Unit Dominance Analysis and Effect of the Winning Unit on Outcomes after Double-Unit Umbilical Cord Blood Transplantation in Adults with Acute Leukemia: A Retrospective Study on Behalf of Eurocord, the Cord Blood Committee of Cellular Therapy, Immunobiology Working Party, and the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation.Biol Blood Marrow Transplant . 24(8):1657-1663, 2018.
  • Paviglianiti A, Dalle JH, Ayas M, Boelens JJ, Volt F, Iori AP, de Souza MP, Diaz MA, Michel G, Locatelli F, Jubert C, Yakoub-Agha I, Bittencourt H, Bertrand Y, Kenzey C, Tozatto Maio K, Hayashi H, Rocha V, Bader P, Gluckman E, Ruggeri A. Low Body Mass Index Is Associated with Increased Risk of Acute GVHD after Umbilical Cord Blood Transplantation in Children and Young Adults with Acute Leukemia: A Study on Behalf of Eurocord and the EBMT Pediatric Disease Working Party.Biol Blood Marrow Transplant . 24(4):799-805, 2018.
  • Yoshinaga , Kanda J, Aisa Y, Hagiwara S, Mori T, Fukuda T, Ishida Y, Hashimoto H, Iwato K, Kanda Y, Kurokawa M, Nakazawa H, Ota S, Uchida N, Ichinohe T, Atsuta Y, Takaori-Kondo A.Impact of HIV Infection on Transplant Outcomes after Autologous Peripheral Blood Stem Cell Transplantation: A Retrospective Study of Japanese Registry Data. Biol Blood Marrow Transplant. 7(4): 138-144, 2018.
  • Hayashi H, Ruggeri A, Volt F, Cornelissen JJ, Socié G, Sengeloev H, Michallet M, Karakasis D, Petersen E, Cahn JY, Veelken H, Mercier M, Rohrlich PS, Rafii H, Kenzey C, Xavier E, Duarte RF, Basak GW, Rocha V, Gluckman E; Eurocord and the Complications and Quality of Life WP of EBMT. Chronic graft-versus-host disease features in double unit cord blood transplantation according to National Institutes of Health 2005 cGVHD Consensus criteria. Bone Marrow Transplant. 53(4):417-421, 2018.
  • Kamitori T, Umeda K, Tasaka K, Ogata H, Mikami T, Kato I, Hiramatsu H, Kondo T, and Adachi S. Chronic myeloid leukemia following treatment for bilateral retinoblastoma. Pediatric Blood & Cancer. 2018.
  • Kawaguchi K, Umeda K, Hiejima E, Iwai A, Mikami M, Nodomi S, Saida S, Kato I, Hiramatsu H, Yasumi T, Nishikomori R, Kondo T, Takaori-Kondo A, Heike T, and Adachi S. Influence of post-transplant mucosal-associated invariant T cell recovery on the development of acute graft-versus-host disease in allogeneic hematopoietic stem cell transplantation. Int J Hematol. 2018
  • Arai Y, Matsui H, Jo T, Kondo T, Takaori-Kondo A. Response to the comment by Cirasino L and Semeraro S. "Need to direct immune thrombocytopenia therapy towards shared goals" Direct and indirect comparisons to determine the first choice for newly diagnosed primary immune thrombocytopenia (ITP) in adults. Haematologica. 2018.
  • Ogata M, Takano K, Moriuchi Y, Kondo T, Ueki T, Nakano N, Mori T, Uoshima N, Nagafuji K, Yamasaki S, Shibasaki Y, Sakai R, Kato K, Choi I, Jo Y, Eto T, Kako S, Oshima K, Fukuda T. Effects of prophylactic foscarnet on HHV-6 reactivation and HHV-6 encephalitis in cord blood transplant recipients: a prospective multicenter cohort study with a historical control group. Biol Blood Marrow Transplant. 2018.
  • 濱田 涼太，吉田 路子，宮坂 淳介，南角 学，近藤 忠一，高折 晃史，池口 良輔，松田 秀一。同種造血幹細胞移植前の運動耐容能が移植後の身体機能に与える影響-移植前リハビリテーション介入の可能性 日本造血細胞移植学会誌. 2018.
  • Yoshimura K, Yano I, Yamamoto T, Kondo T, Kawanishi M, Isomoto Y, Yonezawa A, Takaori-Kondo A, and Matsubara K. Pharmacokinetic and Pharmacodynamic Markers of Mycophenolic Acid Are Associated with Effective Prophylaxis for Acute Graft-versus-Host Disease and Neutrophil Engraftment in Cord Blood Transplant Patients.Biol Blood Marrow Transplant. 2018.
  • Kawajiri-Manako C, Sakaida E, Ohwada C, Miyamoto T, Azuma T, Taguchi J, Mori T, Hasegawa Y, Kondo T, Yujiri T, Yoshimitsu M, Imada K, Kurahashi S, Kahata K, Ichinohe T, Hirokawa M, Atsuta Y, Nakaseko C. The efficacy and long-term outcomes of autologous stem cell transplantation in POEMS syndrome: A nationwide survey in Japan. Biol Blood Marrow Transplant. 2018.
  • Arima H, Fujimoto M, Nishikori1 M, Kitano T, Kishimoto W, Hishizawa M, Kondo T, Yamashita K, Hirata M, Haga H, Takaori-Kondo A. Prognostic impact of activation-induced cytidine deaminase expression for patients with diffuse large B-cell lymphoma. Leuk Lymphoma. 2017.
  • Arai Y, Choi U, Corsino CI, Koontz SM, Tajima M, Sweeney CL, Black MA, Feldman SA, Dinauer MC, Malech HL. Myeloid conditioning with c-kit-targeted CAR-T cells enables donor stem cell engraftment. Mol Ther. 2018;26(5):1181-1197.
  • Arima N, Kanda J, Tanaka J, Yabe T, Morishima Y, Kim SW, Najima Y, Ozawa Y, Eto T, Kanamori H, Mori T, Kobayashi N, Kondo T, Nakamae H, Uchida N, Inoue M, Fukuda T, Ichinohe T, Atsuta Y, Kanda Y. Homozygous HLA-C1 is Associated with Reduced Risk of Relapse after HLA-Matched Transplantation in Patients with Myeloid Leukemia. Biol Blood Marrow Transplant. 24(4): 717-725, 2018.
  • Yamazaki H, Kondo T, Aoki K, Yamashita K, Takaori-Kondo A. Occurrence and improvement of renal dysfunction and serum potassium abnormality during administration of liposomal amphotericin B in patients with haematological disorders: A retrospective analysis. Diagn Microbiol Infect Dis. 90(2): 123-131, 2018.
  • Arai Y, Kondo T, Shigematsu A, Tanaka J, Ohashi K, Fukuda T, Hidaka M, Kobayashi N, Iwato K, Sakura T, Onizuka M, Ozawa Y, Eto T, Kurokawa M, Kahata K, Uchida N, Atsuta Y, Mizuta S, and Kako S. Improved prognosis with additional medium-dose VP16 to CY/TBI in allogeneic transplantation for high risk ALL in adults. Am J Hematol. 93(1): 47-57, 2018.
  • Arai Y, Matsui H, Jo T, Kondo T, Takaori-Kondo A. Comparison of up-front treatments for newly diagnosed immunethrombocytopenia - a systematic review and network meta-analysis.Haematologica. 103(1): 163-171, 2018.
  • Kondo T. Significance of an intensified myeloablative conditioning regimen for myeloid malignancy and acute lymphoblastic leukemia. Journal of Hematopoietic cell transplantation. 7(1): 1-8, 2018.
  • Kawamura K, Kako S, Mizuta S, Ishiyama K, Aoki J, Yano S, Fukuda T, Uchida N, Ozawa Y, Eto T, Iwato K, Kanamor H, Kahata K,Kondo T, Sawa M, Ichinohe T, Atsuta Y, Kanda Y. Comparison of Reduced-Intensity Conditioning with Fludarabine/Busulfan and Fludarabine/Melphalan in Allogeneic Transplant Recipients 50 Years or Older. Biol Blood Marrow Transplant. 23(12): 2079-2087, 2017.
  • Yoshimura K, Yano I, Yamamoto T, Kawanishi M, Isomoto Y, Yonezawa A, Kondo T, Takaori-Kondo A, and Matsubara K. Population pharmacokinetics and pharmacodynamics of mycophenolic acid using prospective data in patients undergoing hematopoietic stem cell transplantation. Bone Marrow Transplant. 53(1): 44-51, 2018.
  • Hijiya K, Chen-Yoshikawa TF, Miyagawa-Hayashino A, Kondo T, Aoyama A, Haga H, Takaori-kondo A, Date H. Pulmonary endothelial chimerism after hematopoietic stem cell transplantation. Surg Today. 48(1): 101-109, 2018.
  • Tachibana T, Kanda J, Machida S, Saito T, Tanaka M, Najima Y, Koyama S, Miyazaki T, Yamamoto E, Takeuchi M, Morita S, Kanda Y, Kanamori H, Okamoto S; Kanto Study Group for Cell Therapy (KSGCT). Deferasirox for the treatment of iron overload after allogeneic hematopoietic cell transplantation: multicenter phase I study (KSGCT1302). Int J Hematol. 107(5):578-585, 2018.
  • Kameda K, Kako S, Hayakawa J, Akahoshi Y, Komiya Y, Harada N, Ugai T, Ishihara Y, Kawamura K, Sakamoto K, Sato M, Kanda J, Tanihara A, Wada H, Terasako-Saito K, Kimura SI, Kikuchi M, Nakasone H, Kanda Y. Safety of avoiding systemic corticosteroid administration for grade II acute graft-versus-host disease limited to the skin. Ann Hematol. 97(1):169-179, 2018.
  • Nakasone H, Terasako-Saito K, Hirano T, Wake A, Shimizu S, Kurita N, Yamazaki E, Usuki K, Akazawa K, Kanda J, Minauchi K, Yamamoto G, Tanimoto S, Kamoshita M, Yokoyama Y, Miyaoka E, Ota S, Kako S, Izutsu K, Kanda Y. Targeting complete response with upfront bortezomib consolidation versus observation after the achievement of complete response following autologous transplantation for multiple myeloma (TUBA study). Hematol Oncol 36(1):202-209, 2018.
  • Kataoka K, Iwanaga M, Yasunaga JI, Nagata Y, Kitanaka A, Kameda T, Yoshimitsu M, Shiraishi Y, Sato-Otsubo A, Sanada M, Chiba K, Tanaka H, Ochi Y, Aoki K, Suzuki H, Shiozawa Y, Yoshizato T, Sato Y, Yoshida K, Nosaka K, Hishizawa M, Itonaga H, Imaizumi Y, Munakata W, Shide K, Kubuki Y, Hidaka T, Nakamaki T, Ishiyama K, Miyawaki S, Ishii R, Nureki O, Tobinai K, Miyazaki Y, Takaori-Kondo A, Shibata T, Miyano S, Ishitsuka K, Utsunomiya A, Shimoda K, Matsuoka M, Watanabe T, Ogawa S. Prognostic relevance of integrated genetic profiling in adult T-cell leukemia/lymphoma. Blood. 131(2): 215-225, 2018